In order to strengthen the supervision and management of drug clinical trials, promote the transparency of drug clinical trial information, and protect the rights, benefits and safety of trial subjects, China Food and Drug Administration (CFDA) recently issued the No. 28 Announcement, which requires to carry out registration and disclosure of drug clinical trial information.